LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 1,862 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Doctors Hesitate to Prescribe Ortho Evra
Aug-16-07 Nashville, TN: A group of doctors in Tennessee has decided to stop prescribing the Ortho Evra patch to patients over concerns that the device could increase their risk of blood clots or other problems. In a letter to their patients, the doctors cited a study which showed that women who use the Ortho Evra patch are at an increased risk of deep vein thromb... - Paxil: "Absolutely do not take it."
Sep-15-07 Westminster, CO: When Rhonda Aldrich found out she was pregnant, she told her doctor she was taking Paxil and asked if there were any concerns about the drug. She notes her doctor said, "There is nothing on the label stating that Paxil will harm the baby." So Aldrich continued taking Paxil. Aldrich says that while she was in labor, the baby's oxygen... - Attorney Subpoenas J&J, AstraZeneca and Lilly for Hidden Antipsychotic Data Part I
Sep-10-07 Washington, DC Alaska attorney Jim Gottstein has issued subpoenas for the discovery of any suppressed data on the atypical antipsychotic drugs Zyprexa , Risperdal, and Seroquel which he says is necessary before a Forced Drugging Petition can possibly be considered for approval for a client he is representing. Mr Gottstein contends that the informatio... - Lawsuits Against Glaxo Rise as Avandia Sales Plummet
Aug-1-07 Washington, DC: A study released in July 2007, by the Federal Agency for Health Care Research and Quality, reported that the older diabetes drugs, available for as little as $10 a month, are as safe and effective as the newer drugs like Avandia (rosiglitazone), which costs between $131 and $262 a month. On July 20, 2007, Science Daily reported that li... - Malignant Mesothelioma: Asbestos Exposure the only Known Cause to Deadly Disease
Jul-31-07 Deweyville, TX Exposure to asbestos and, specifically, the onset of exposure-related diseases such as malignant mesothelioma will likely result in asbestos remaining in the courts for a very long time. Even though asbestos use has been minimized in the wake of concerns over exposure and health deterioration, the long latency period impacts workers who... - Arbitration Panels Award Damages in Stockbroker Complaints
Sep-3-07 New York, NY Investors who have been wronged by their stockbrokers have the option of taking their claim to Securities Stockbroker Arbitration to regain some of the money they lost due to the unethical practices of their stockbroker. In fact, many investors might be legally bound to go through an arbitration process rather than through the courts. Une... - Consumer Protection Board Fights Against Credit Card Abuse
Jul-26-07 New York, NY As part of its fight against credit card abuse , the New York State Consumer Protection Board has asked credit card users to send in their "horror stories" about unfair credit card industry practices. According to the Consumer Protection Board, most consumers have at least seven credit cards. Unfortunately, the companies that issue the car... - What's With the Beef?
Jul-25-07 Suffolk, VA In the first six months of 2007, the US Food Safety and Inspection Service recalled over seven million pounds of red meat. And the number of cases of people getting sick from contaminated beef is growing as fast as E. coli in an overcrowded cattle pen. What's up with our beef? Are we going to have a repeat of the ConAgra case? (In July 2... - Accutane - Another Case of Too Little Too Late
Apr-12-06 Accutane is prescribed to treat a type of severe acne called nodular acne which causes red, swollen, tender lumps to form under the skin. Accutane is supposed to be used only when all other treatments, including antibiotics, have failed. The treatment usually lasts 4 or 5 months, at a cost of about $3000, including lab tests and doctor's visits. The drug... - CDC Leads SSRI Disinformation Media Blitz
Jul-20-07 Washington, DC: In a June 27, 2007 press release that made headlines all over the world the US Centers for Disease Control announced that birth defects associated with the use of antidepressants by pregnant women are rare. As proof for this claim, the CDC cited two new studies published in the New England Journal of Medicine. Over the following 2 week... - Ohio Lawsuit Claims Death caused by Kugel Mesh Patch
Jul-19-07 Akron, OH In May, the estate of a 68-year-old Ohio man who died in 2004 after hernia surgery sued the makers of a device used in that surgery. The device was the Composix Kugel Mesh Patch, made by Davol Inc. This is not the first lawsuit claiming injuries or death resulting from a defective Composix Kugel Mesh Patch. The patch is one of a group of... - AMO MoisturePlus: A Young Man's Story
Jul-16-07 Connellsville, PA Kevin Carraway knew something was wrong when he began having severe eye pain. "I went for a pair of glasses last year, and the optician gave me a pair of contacts, along with a kit containing AMO MoisturePlus Multi-Purpose Solution . They wanted my eyes to get used to the new prescription, by wearing the contacts," says Carraway, 27. ... - Pollution Watchdog: Public Beach Pollution Worse in 2007
Aug-16-07 Buffalo, NY The Natural Resource Defense Council has published its annual list of the best--and worst--public beaches in the US, with findings that shoreline pollution has gotten worse. This pollution can make swimmers sick and lead to long-term problems for local residents and ecosystems. According to the NRDC report, this year storm water has washed... - Avandia FDA Mole Hawks Lethal Medication Patches
Aug-12-07 Washington, DC: Douglas Arbesfeld, the pharmaceutical industry's mole inside the FDA, recently revealed his existence quite by accident when he attempted to destroy the reputation of cardiologist Dr. Steve Nissen by sending a malicious email to reporters after Dr. Nissen published a study that found the diabetes drug Avandia possibly increases the risk o... - More Zyprexa Lawsuits
Aug-10-07 Indianapolis, IN A 2004 Dear Doctor letter sent from Eli Lilly to physicians in the U.S. noted the risks associated with Zyprexa . According to the letter, "Hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical antipsychotics including Zyprexa." Now, o... - Ortho Evra Patch Versus Traditional Contraceptives
Aug-9-07 Houston, TX: Ortho-McNeil introduced the Ortho Evra birth control patch in 2002. At that time, many women and their doctors were excited, thinking of it as a major contraceptive breakthrough. Whereas a woman on birth control pills had to take one daily, the Ortho Evra patch would be applied to the skin once a week. Although this was highly convenient,... - Legal ADHD Speed - Becoming Drug Of Choice For Americans
Mar-21-06 A study published online in the February 2006, Journal of Drug and Alcohol Dependence, that examined data from a 2002 survey of about 67,000 households, estimates that more than 7 million Americans have misused stimulant drugs meant to treat ADHD, and "substantial numbers of teenagers and young adults appear to show signs of addiction, according to a compreh... - Tequin - Blood-Sugar Problems Ain't All
Mar-17-06 The antibiotic, Tequin, manufactured by Bristol Myers Squibb, has been linked to both hypoglycemia and hyperglycemia by researchers who examined treatment outcomes associated with various antibiotics in approximately 1.4 million patients, 66 years of age and older, between April 2002 and March 2004. A team of Canadian scientists from the Institute of Clin... - Panacryl Sutures: Another suture experiment brought to you by Ethicon
Jun-26-07 Pittsburgh, PA Ethicon Inc. has much to answer for. It is facing an undisclosed number of lawsuits from patients who have suffered or died because of alleged suture failure, the most recent wave of lawsuits relating to the absorbable Panacryl suture . Now a Pennsylvania jury has awarded $15 million damages to a victim's family because another Ethicon s... - ADHD Experts Head to Washington - Is the FDA up to the Task?
Mar-14-06 Heavy-hitters from across the country are heading to Washington this month to debate representatives of the pharmaceutical industry during FDA hearings on the controversy surrounding the over-prescribing of attention deficit drugs to children. The International Center for the Study of Psychiatry and Psychology (ICSPP) will be represented by five of the le...